An entrepreneur and strategic visionary with a decade’s experience in founding and leading innovative ventures. Extensive scientific and academic background with a PhD in Biotechnology. Loves the challenge of transforming scientific discoveries into commercial products and building innovation. Has successfully founded and led and exited ventures, including two M&As and two listings on the Swedish exchange market. Co-founded Epigenica together with Simon.
A strategic leader with a proven track record of operational excellence in the pharmaceutical industry and beyond. Holds a PhD in Molecular Neurobiology and an Executive MBA, bringing deep experience in drug discovery and technology licensing. Has managed teams and projects within Multiple Sclerosis, pain, epilepsy, Alzheimer’s disease, and gene therapy.
An accomplished scientist and academic specializing in biochemistry and biophysics. An Associate Professor at Karolinska Institutet and has conducted research at renowned institutions such as Harvard University. Took advanced technology venture courses at The New York Academy of Sciences, showing his dedication in bringing solutions for technology gaps to a commercial scene and for a wider use. Co-founded Epigenica together with Mohamad.
A scientist with a passion for deepening our understanding of genetics and epigenetics through enabling technology tools. Has a degree in biotechnology from Bangalore, India and studied molecular biology and genetics at Lund University and the European Molecular Biology Laboratory in Heidelberg. Has a PhD from Karolinska Institutet where she has contributed significantly to the development of a novel quantitative method to study chromatin dynamics.
Board of Directors
Anders Nordström, Chairman
Other current positions: Chairman of the Board at FenoMark Diagnostics, Moleculent and Offspring Biosciences AB. Partner at Colibri Ventures.
Previous positions: Executive Vice President at Pharmacia, Board Member and CFO at Phadia AB, Board Member Halo Genomics AB, VP Finance & Operations at ArthroCare International.
Eva Walde
Other current positions: Board Member, Co-owner and Investor at Scale Up Life Science Invest, Board Member at FrostPharma AB, Board Member at Sedana Medical.
Previous positions: Vice President Marketing at Olink Proteomics, VP Commercial Operations International Region at Thermo Fisher Scientific, Global Brand Director at Phadia AB, Strategic Development Manager at Pfizer.
Gustav Notander
Other current positions: Board Member at Molecular Attraction AB, Board Member at Geras Solutions, Board Member TIRmed Pharma, Investment Manager at Almi Invest
Previous positions: IP Manager at KTH Holding AB, Founder of Scanditerraneo, Business Development Coach at KTH Innovation
Yang Shi, PhD
Other current positions: Professor of Epigenetics at the University of Oxford
Previous positions: Professor of Cell Biology and C. H. Waddington Professor of Pediatrics at Harvard Medical School, Professor of Pediatrics at Division of Newborn Medicine at Boston Children’s Hospital, Postdoc at Princeton University.
Simon Elsässer, PhD
Board Member and CSO Epigenica
This website uses cookies. By continuing to use this site, you accept our use of cookies.